Biohaven Ltd.
BHVN
$8.96
-$0.24-2.61%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 10.32% | 16.08% | 12.47% | 10.61% | -18.64% |
| Total Depreciation and Amortization | -8.05% | -17.66% | 57.99% | -11.93% | -8.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.43% | -19.80% | 185.41% | -83.51% | 198.51% |
| Change in Net Operating Assets | -440.16% | -226.30% | -116.22% | 525.15% | 27.43% |
| Cash from Operations | -14.74% | 10.33% | 13.23% | -1.70% | 3.29% |
| Capital Expenditure | -- | 38.46% | 94.42% | 49.46% | -840.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 210.79% | -108.32% | 1,177.39% | -109.26% | 287.85% |
| Cash from Investing | 210.72% | -108.33% | 1,161.15% | -109.43% | 288.05% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -5.50% | 155,178.69% | -88.67% | 191.87% | -99.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Financing | -5.18% | 154,650.82% | -99.95% | 67,604.61% | -99.86% |
| Foreign Exchange rate Adjustments | -- | -100.00% | 135.00% | -273.91% | -73.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -0.16% | 128.99% | -70.76% | 45,007.48% | -98.99% |